Table I.
Characteristics and quality score of the studies.
| Author, year | Country | Ethnicity | Antibody supplier | Cases | Ctr | Risk of cancer | Follow-up outcome | Quality | (Refs.) |
|---|---|---|---|---|---|---|---|---|---|
| Jiang et al, 2015 | China | Asian | Santa Cruz Biotechnology, Inc. | 227 | – | – | Negative | 8 | (34) |
| Jiang et al, 2009 | China | Asian | Santa Cruz Biotechnology, Inc. | 78 | 20 | Increased | – | 8 | (33) |
| Zhu et al, 2015 | China | Asian | Santa Cruz Biotechnology, Inc. | 95 | 20 | Increased | – | 7 | (32) |
| A et al, 2014 | China | Asian | Cusabio Technology LLC | 66 | 66 | Increased | – | 8 | (31) |
| Cui et al, 2014 | China | Asian | Santa Cruz Biotechnology, Inc. | 105 | – | – | – | 8 | (35) |
| Zhang et al, 2011 | China | Asian | Bioss, Inc. | 76 | 30 | Increased | – | 8 | (30) |
| Zhang et al, 2014 | China | Asian | Shanghai Long Island Biotec. Co., Ltd. | 39 | 39 | Increased | – | 8 | (29) |
| Zhang et al, 2015 | China | Asian | Santa Cruz Biotechnology, Inc. | 64 | 40 | Increased | Negative | 8 | (28) |
| Hua et al, 2013 | China | Asian | Santa Cruz Biotechnology, Inc. | 75 | 14 | Increased | – | 8 | (27) |
| Wang et al, 2003 | China | Asian | Santa Cruz Biotechnology, Inc. | 86 | 57 | Increased | Negative | 8 | (26) |
| Yao et al, 2004 | USA | America | Santa Cruz Biotechnology, Inc. | 86 | – | – | – | 8 | (12) |
| Wei et al, 2009 | China | Asian | Santa Cruz Biotechnology, Inc. | 68 | – | – | Negative | 8 | (25) |
| Hun et al, 2013 | Japan | Asian | Santa Cruz Biotechnology, Inc. | 268 | – | – | – | 8 | (36) |
Ctr, control; -, data not provided.